MORE ATTIA Medicine 3.0 Medicine 3.0 is about switching the focus from treatment to prevention
No special aftercare is needed
CJC-1295 and Ipamorelin are not listed under the Misuse of Drugs Act 1971 and are supplied in the UK as research chemicals for in vitro and non-human laboratory use only
Referencias berg, S., Webb, D.-L., Nordin, E., Hellstrm, P
Although doctors may recommend B12 injection for this purpose when weakness is related to peripheral neuropathy, more research is needed on effectiveness, and Medicare doesnt consider this medically necessary
As of the 28 January 2025 revision it is indicated not only for glycaemic control in type 2 diabetes, but also to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease